Michael J Cavnar, MD: Clinical Trials

2 trials sponsored by Michael J Cavnar, MD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated. 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Terminated 1
Phase 21Recruiting 1

Follow Michael J Cavnar, MD: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
Hepatic Artery Infusion Pump (HAIP), Standard Treatment, Community Treatment - Colorectal Cancer Metastatic, Intrahepatic Cholangiocarcinoma
Phase 2RecruitingMichael J Cavnar, MD802026-01-232026-02-04
Codman Catheter/Synchromed Pump Hepatic Artery Chemotherapy for Unresectable Colorectal Metastases/Intrahepatic Cholangiocarcinoma
Hepatic artery infusion pump placement using the Synchromed II pump and the Codman tapered arterial catheter., Hepatic artery infusion pump floxuridine and dexamethasone, Systemic chemotherapy for colorectal liver metastases - Bile Duct Neoplasms, Colorectal Neoplasms
Not applicableTerminatedMichael J Cavnar, MD212020-05-012023-07-25

Conditions studied

Cholangiocarcinoma (2)  ·  Bile Duct Neoplasms (1)  ·  Colorectal Neoplasms (1)

Interventions

Community Mental Health Services (1)  ·  Dexamethasone (1)

Countries

United States (2)

Top investigators

Michael Cavnar, MD (1)

Results publications

PMID 36410913